Close Menu

Stanford

Researchers at Affymetrix, Genentech, and Stanford University's Genome Technology Center have created a new array-based resequencing assay that they claim is scalable enough to compete with second-generation sequencing platforms.

Short Reads: Mar 31, 2009

Premium

Helicos, Agencourt, Illumina, RainDance Technologies, Ontario Institute for Cancer Research, VWR International, ZyGem, University of Queensland, University of Michigan, Genomatix

Paired Ends: Mar 31, 2009

Premium

Greg Porreca, Adam Cohen, David Cumming, Michael Deem, Jim Lupski, Amy McGuire, Antoine van Oijen, Ian Ratcliffe

Bloggers Abuzz

Premium

Bloggers discuss the US stimulus, mandatory open access policies, the Vatican's take on evolution, and Merck's new venture.

Howard Chang, William Kaelin, Yitzhak Tor

Patent Watch: Mar 13, 2009

Premium

Stanford University, Maine Medical Center Research Institute, PerkinElmer Cellular Technologies Germany Awarded US Patents

IP Roundup: Mar 10, 2009

Premium

Accelr8, Whitehead Institute for Biomedical Research, Dana-Farber Cancer Institute, Stanford University, Aperio Technologies

Quake confirmed in an e-mail message last week that he used a Helicos sequencer for the project and said that he plans to publish the results of the study.

NHLBI in late January put out an RFP for the program, which calls for researchers to develop proteomics technologies and apply them to solve clinical puzzles. It is set to begin early next year, shortly after its current two major proteomics initiatives expire.

The deal brings to six the number of academic institutions from which Fate has licensed IP related to using small molecules to induce pluripotency in stem cells for therapeutic effect, drug discovery, and matched cell-replacement therapies.

Pages

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.